Signature Equity Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Signature Equity Partners's MRK Position: Q2 2026 in Review
Signature Equity Partners reduced its Merck (MRK) stake by 59% in Q2 2026, selling an estimated $171K and leaving 1,008 shares worth $129K. The position accounts for 0.06% of the portfolio, ranked #251.
Signature Equity Partners first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $297K in Q1 2026. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Signature Equity Partners held 1,008 shares of Merck worth $129K as of Q2 2026.
- Signature Equity Partners sold 1,462 Merck shares in Q2 2026, an estimated $171K.
- Merck made up 0.06% of Signature Equity Partners's portfolio in Q2 2026, its #251 holding.
- Signature Equity Partners first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
- Signature Equity Partners's Merck position peaked at $297K in Q1 2026.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.